Be a more knowledgeable, successful laboratory in just five minutes each week!
Sign up to receive Dark Daily, a free email newsletter with laboratory news, strategies, tips, and techniques and get the Special Report: 2008 Trends in Clinical Laboratory Pathology Management free when you sign up.

Laboratory News
Massachusetts Blue Cross Blue Shield Tries Flat Fee Reimbursement Plan for Providers
Different reimbursement models for physicians are emerging
as the healthcare system attempts to encourage early detection and preventative
care. Blue Cross and Blue Shield of Massachusetts (BCBSM),
the state's largest insurer, is offering its participating providers the option
of switching out of a traditional fee-for-service model. Now, providers can opt to be paid a flat fee
per patient per year model. The specific amount for each patient will be
adjusted for age and illness. Providers will also be eligible for performance
bonuses of up to 10% for quality improvement.
BCBSM believes this different reimbursement model can
deliver higher outcomes. As it does, it should reduce the year-by-year increase
in the cost of care. Chris Murphy,
spokesman for Blue Cross Blue Shield of Massachusetts, said that the insurer
doesn't expect to cut costs, but to slow healthcare spending through
efficiencies. The company estimates that
spending would grow at 4% to 6% per year if providers enrolled in the new
model, as opposed to 10% to 12% annually today.
"Better outcomes have demonstrated that they lead to savings," Murphy
said. "We think we'll see more
innovative and creative care on the provider level."
The new payment model will be rolled out through Blue Cross
Blue Shield of Massachusetts' HMO. The
model will be offered through five-year contracts. BCBSM expects that providers will begin to
sign on for the new reimbursement program in the next few months.
Some parties are concerned that this new payment model
represents a return to capitation-where a fixed prepayment, per each patient covered,
is made to a healthcare provider. Murphy responds that this is not the case,
since the per-patient reimbursement will be risk-adjusted, and because
incentive rewards are built into the model.
Blue Cross Blue Shield of Massachusetts has not yet released
the specific amounts it will pay for each patient. It is not likely that providers will accept
this new reimbursement arrangement until they have access to that
information.
Laboratory directors and pathologists can expect to see more
attempts by regional payers to reimburse physicians and hospital in different
ways than either traditional fee-for-service or straight capitation. In order to encourage providers to improve
patient outcomes, new schemes for reimbursement will be introduced. However, providers have reason to be
skeptical about new approaches to provider reimbursement. Too often in the past
20 years, a different reimbursement scheme has simply meant less money to the
provider for the same service. Thus, the
health insurance industry must offer credible reimbursement programs that effectively
reward a provider by paying higher reimbursement for higher outcomes. Any other consequence to these new
reimbursement plans will cause physicians to reject them en masse.
Related
Articles: